GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
GH Research PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026
$18.28+0.13 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $1.22B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
GH Research has not reported a dividend
No dividend per share appears in GH Research's annual filings since fiscal 2018.